Stereotactic Ablative Body Radiotherapy with w Central High Dose using CyberKnife for Metastatic Lung Tumors
Hayashi K, Suzuki O, Shiomi H, Ono H, Setoguchi A, Nakai M, Nakanishi E, Tatekawa S, Ose N, Hirata T, Tamari K, Seo Y, Funaki S, Isohashi F, Shimizu S, Shintani Y, Ogawa K | BMC Cancer | 2023
Challenges of BCLC stage C hepatocellular carcinoma: Results of a single-institutional experience on stereotactic body radiation therapy
Que J, Lin CH, Lin LC, Ho CH | Medicine (Baltimore) | 2020
Experience with Normal Breathhold Planning Scans for Radiosurgery of Moving Targets with Live Tracking
Grimm J, Naidoo SF, Yossef K, Shukla G, Scofield CJ, Searfoss AC, Zulkoski MA, Tanyi JA, Mackley HB, Mahadevan | eCollection | 2023
CyberKnife Xsight Versus Fiducial-Based Target-Tracking: A Novel 3D Dosimetric Comparison in a Dynamic Phantom
Klein TJ, Gill S, Ebert MA, Grogan G, Smith W, Alkhatib Z, Geraghty J, Scott AJD, Brown A, Rowshanfarzad P | Radiat Oncol | 2022
Salvage Stereotactic Reirradiation for Intraprostatic Cancer Recurrence: A Large Retrospective Study
Allali S, Loap P, Bibault JE, Krepps S, Deforge A, Moreau D, Durdux C, Giraud P | Prostate | 2023
Large Prostate Volume Does Not Negatively Impact Health-Related Quality of Life in Patients with Prostate Cancer Treated with Ultra-hypofractionated Stereotactic Body Radiotherapy
Piotr Milecki, Anna Adamska, Anna Rucinska, Grzegorz Pałucki, Agnieszka Szumiło, Agnieszka Skrobała, Agata Jodda, Michał Michalak | J Pers Med | 2023
Stereotactic Body Radiation Therapy for Prostate Cancer: A Study Comparing 3-year Genitourinary Toxicity Between CyberKnife and Volumetric-Modulated Arc Therapy by Propensity Score Analysis
Makoto Ito, Yasuo Yoshioka, Yuuki Takase, Junji Suzuki, Hironori Takahashi, Yoshitaka Minami, Ami Sakuragi, Yukihiko Oshima, Takahito Okuda, Kojiro Suzuki | Radiat Oncol | 2023
Robotic Stereotactic Body Radiotherapy for Localized Prostate Cancer: Final Analysis of the German Hypostat Trial
David Krug, Detlef Imhoff, Alfred Haidenberger, Nicole Heßler, Jane Schäfer, Stefan Huttenlocher, Georgios Chatzikonstantinou, Christoph Fürweger, Ulla Ramm, Inke R König, Felix Chun, Michael Staehler, Claus Rödel, Alexander Muacevic, Reinhard Vonthein, Jürgen Dunst, Oliver Blanck | Strahlenther Onkol | 2023
Survival and Prognostic Factors of Ultra-Central Tumors Treated with Stereotactic Body Radiotherapy
Salvestrini V, Duijm M, Loi M, Nuyttens JJ | Cancers (Basel) | 2022
Robotic CyberKnife Radiosurgery for the Treatment of Choroidal and Ciliary Body Melanoma
Liegl R, Schmelter V, Fuerweger C, Ehret F, Priglinger S, Muacevic A, Foerster P | Am J Ophthalmol | 2023
Lung Sparing and Ribcage Coverage in Total Body Irradiation Delivered by Helical TomoTherapy
Köksal M, Baumert J, Schoroth F, Scafa D, Koch D, Leitzen C, Sarria GR, Giordano FA, Chatzikonstantinou G, Schmeel LC | Eur J Med Res | 2022
Outcomes of fractionated CyberKnife radiosurgery in patients with choroidal malignant melanoma
Ceyda Baskan, Ebru Atasever Akkas, Sabite Emine Gökce, Sibel Ozdogan | Acta Oncol | 2022
Potential Clinical Significance of Overall Targeting Accuracy and Motion Management in the Treatment of Tumors That Move With Respiration: Lessons Learnt From a Quarter Century of Stereotactic Body Radiotherapy From Dose Response Models – PubMed (nih.gov)
Mahadevan A, Emami B, Grimm J, Kleinberg LR, Redmond KJ, Welsh JS, Rostock R, Kemmerer E, Forster KM, Stanford J, Shah S, Asbell SO, LaCouture TA, Scofield C, Butterwick I, Xue J, Muacevic A, Adler JR | Front Oncol | 2021
Intensity-modulated radiotherapy versus stereotactic body radiotherapy for prostate cancer (PACE-B): 2-year toxicity results from an open-label, randomised, phase 3, non-inferiority trial
Tree AC, Ostler P, van der Voet H, Chu W, Loblaw A, Ford D, Tolan S, Jain S, Martin A, Staffurth J, Armstrong J, Camilleri P, Kancherla K, Frew J, Chan A, Dayes IS, Duffton A, Brand DH, Henderson D, Morrison K, Brown S, Pugh J, Burnett S, Mahmud M, Hinder V, Naismith O, Hall […]
Estimation of Annual Secondary Lung Cancer Deaths Using Various Adjuvant Breast Radiotherapy Techniques for Early-Stage Cancers
Jean-Philippe Pignol, Nienke Hoekstra, Derek Wilke, Hannah Dahn, Maureen Nolan, Frank Vicini | Front Oncol | 2021
Skin Toxicity in Early Breast Cancer Patients Treated with Field-In-Field Breast Intensity-Modulated Radiotherapy versus Helical Inverse Breast Intensity-Modulated Radiotherapy: Results of a Phase III Randomised Controlled Trial
K Joseph, L J Vos, Z Gabos, N Pervez, S Chafe, K Tankel, H Warkentin, S Ghosh, J Amanie, K Powell, L-A Polkosnik, S Horsman, M MacKenzie, S Sabri, M B Parliament, J Mackey, B Abdulkarim | Clin Oncol (R Coll Radiol) | 2021
Multi-institutional feasibility study of a fast patient localization method in total marrow irradiation with helical tomotherapy: a global health initiative by the international consortium of total marrow irradiation
Takahashi Y, Vagge S, Agostinelli S, Han E, Matulewicz L, Schubert K, Chityala R, Ratanatharathorn V, Tournel K, Penagaricano JA, Florian S, Mahe MA, Verneris MR, Weisdorf DJ, Corvo R, Dusenbery KE, Storme G, Hui SK | Int J Radiat Oncol Biol Phys | 2015
Fast, simple, and informative patient-specific dose verification method for intensity modulated total marrow irradiation with helical tomotherapy
Takahashi Y, Hui SK | Radiat Oncol | 2014
Extramedullary relapse following total marrow and lymphoid irradiation in patients undergoing allogeneic hematopoietic cell transplantation
Kim JH, Stein A, Tsai N, Schultheiss TE, Palmer J, Liu A, Rosenthal J, Forman SJ, Wong JY | Int J Radiat Oncol Biol Phys | 2014
Total body irradiation in allogeneic bone marrow transplantation conditioning regimens: A review
Paix A, Antoni D, Waissi W, Ledoux MP, Bilger K, Fornecker L, Noel G | Crit Rev Oncol Hematol | 2018
